Pharmaceutical manufacturing

In this June 5, 2009, photo a woman has Botox injected at Reveal in Arlington, Va. AbbVie is buying Botox maker Allergan in a cash-and-stock deal the drugmakers value at around $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday, June 25, 2019, that it will pay $120.30 in cash and a portion of AbbVie stock for each Allergan share. (AP Photo/Jacquelyn Martin, File)
June 25, 2019 - 2:39 pm
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
June 14, 2019 - 5:38 am
BERLIN (AP) — German chemical and pharmaceutical company Bayer says it plans to invest some 5 billion euros ($5.6 billion) over the next decade in developing "additional methods to combat weeds." Friday's announcement came as Bayer is engaged in legal battles in the U.S. in which plaintiffs claim...
Read More
This March 26, 2018 photo provided by Ashley Atwater shows her mother, Sally Atwater, outside her home in the Georgetown area of Washington, a few days after leaving the hospital. Atwater's doctor spent two months on calls, messages and dozens of pages of forms to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. (Courtesy Ashley Atwater via AP)
June 03, 2019 - 9:59 am
CHICAGO (AP) — Sally Atwater's doctor spent two months on calls, messages and paperwork to get her an experimental drug he thinks can fight the lung cancer that has spread to her brain and spine. Nancy Goodman begged eight companies to let her young son try experimental medicines for a brain tumor...
Read More
May 29, 2019 - 11:24 am
PHILADELPHIA (AP) — The U.S. attorney's office in Philadelphia says a pharmaceutical company is agreeing to pay $3.5 million to settle claims it paid kickbacks to dermatology providers to encourage them to prescribe their drugs. U.S. Attorney William McSwain said Wednesday the matter involved...
Read More
FILE - This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices. Lilly, one of the three top insulin makers, said Wednesday, May 22, 2019, that it's begun selling its own generic version of Humalog U-100 under the chemical name, Insulin Lispro. (AP Photo/Darron Cummings, File)
May 22, 2019 - 6:45 am
A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices. Lilly, one of the three top insulin makers, said Wednesday that it has begun selling...
Read More
May 20, 2019 - 3:12 pm
WASHINGTON (AP) — The Supreme Court said Monday that a judge must decide whether a dispute between drugmaker Merck and patients who alleged they were injured by its bone-strengthening drug Fosamax can go forward. All nine justices agreed that the case should go back to a lower court for further...
Read More
Rep. Anna Eshoo, D-Calif., right, chair of the House Health Subcommittee, says President Donald Trump and Attorney General William Barr want to take a sledgehammer to health care, as she joins, from left, Rep. Lisa Blunt Rochester, D-Del., House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., at a Democratic event ahead of a House floor vote on the Health Care and Prescription Drug Package, at the Capitol in Washington, Wednesday, May 15, 2019. (AP Photo/J. Scott Applewhite)
May 16, 2019 - 8:07 pm
WASHINGTON (AP) — Democrats pushed legislation buttressing the 2010 health care law and curbing prescription drug prices through the House Thursday, advancing a bill that has no chance of surviving in the Senate or getting President Donald Trump's signature and seemed engineered with next year's...
Read More
FILE - This July 6, 2017 file photo shows prescription drugs in a glass flask at the state crime lab in Taylorsville, Utah. Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions. The lawsuit, filed in federal court Friday, May 10, 2019 also names 15 individual senior executives responsible for sales, marketing and pricing. (AP Photo/Rick Bowmer, File)
May 11, 2019 - 3:13 pm
BOSTON (AP) — Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions...
Read More
President Donald Trump speaks during a event on medical billing, in the Roosevelt Room of the White House, Thursday, May 9, 2019, in Washington. (AP Photo/Evan Vucci)
May 09, 2019 - 12:59 pm
WASHINGTON (AP) — The Latest on President Donald Trump's effort to limit "surprise medical bills" (all times local): 1 p.m. President Donald Trump is ratcheting up pressure on the pharmaceutical industry to lower prices and announcing a new effort to end "surprise medical bills" for patients with...
Read More

Pages